Suppr超能文献

[男性乳腺癌前哨淋巴结活检一例]

[A Case of Sentinel Lymph Node Biopsy for Male Breast Cancer].

作者信息

Yamasaki Yasumoto, Yamasaki Yasuhiro, Tsuboi Jun

机构信息

Dept. of Surgery, Kojima Seikoh Hospital.

出版信息

Gan To Kagaku Ryoho. 2016 Nov;43(12):2429-2431.

Abstract

The patient, a 57-year-old man, observed an elastic hard tumor under his left areola. Ultrasonography showed a circular hypoechoic mass that was 1.5 cm in diameter with a moderately indistinct border. Using fine needle aspiration cytology, the tumor was diagnosed as a ductal carcinoma(T1N0M0, stage I ). The patient underwent a mastectomy and a sentinel lymph node biopsy. We omitted radical axillary lymph node dissection because there were no metastases in the sentinel lymph node according to intraoperative frozen section diagnosis. On histopathology, the patient was diagnosed with papillotubular carcinoma. The tumor was positive for ER and negative for PgR, and the HER2 score was 2+. Postoperatively, oral tamoxifen therapy was administered. There have been no signs of recurrence during 4 years of follow-up. We report the sentinel lymph node biopsy results for the 27 cases of male breast carcinoma in Japan.

摘要

患者为一名57岁男性,其在左乳晕下发现一个质地硬且有弹性的肿瘤。超声检查显示一个直径为1.5厘米的圆形低回声肿块,边界中度不清。通过细针穿刺细胞学检查,该肿瘤被诊断为导管癌(T1N0M0,Ⅰ期)。患者接受了乳房切除术和前哨淋巴结活检。根据术中冰冻切片诊断,前哨淋巴结无转移,因此我们省略了根治性腋窝淋巴结清扫术。组织病理学检查显示,患者被诊断为乳头管状癌。肿瘤雌激素受体(ER)阳性,孕激素受体(PgR)阴性,人表皮生长因子受体2(HER2)评分2+。术后给予他莫昔芬口服治疗。在4年的随访期间未出现复发迹象。我们报告了日本27例男性乳腺癌的前哨淋巴结活检结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验